Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
TAS-0612 by Taiho Oncology for Solid Tumor: Likelihood of Approval
TAS-0612 is under clinical development by Taiho Oncology and currently in Phase I for Solid Tumor. According to GlobalData, Phase...